Kirr Marbach & Co. LLC IN lowered its stake in shares of Innospec Inc. (NASDAQ:IOSP) by 6.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 195,852 shares of the specialty chemicals company’s stock after selling 14,540 shares during the period. Innospec comprises approximately 2.8% of Kirr Marbach & Co. LLC IN’s holdings, making the stock its 13th largest position. Kirr Marbach & Co. LLC IN owned 0.81% of Innospec worth $12,681,000 as of its most recent filing with the SEC.
Several other institutional investors also recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. increased its position in Innospec by 8.8% in the third quarter. JPMorgan Chase & Co. now owns 288,423 shares of the specialty chemicals company’s stock valued at $17,539,000 after buying an additional 23,372 shares in the last quarter. FMR LLC increased its position in Innospec by 15.0% in the fourth quarter. FMR LLC now owns 2,739,249 shares of the specialty chemicals company’s stock valued at $187,639,000 after buying an additional 356,480 shares in the last quarter. New York State Common Retirement Fund increased its position in Innospec by 7.0% in the third quarter. New York State Common Retirement Fund now owns 26,000 shares of the specialty chemicals company’s stock valued at $1,581,000 after buying an additional 1,700 shares in the last quarter. Prudential Financial Inc. increased its position in Innospec by 1.9% in the third quarter. Prudential Financial Inc. now owns 161,250 shares of the specialty chemicals company’s stock valued at $9,806,000 after buying an additional 3,080 shares in the last quarter. Finally, James Investment Research Inc. increased its position in Innospec by 3.5% in the third quarter. James Investment Research Inc. now owns 470,332 shares of the specialty chemicals company’s stock valued at $28,601,000 after buying an additional 15,693 shares in the last quarter. 88.91% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Innospec Inc. (NASDAQ:IOSP) traded up 2.30% during midday trading on Thursday, hitting $62.35. The company’s stock had a trading volume of 66,077 shares. The firm has a 50-day moving average of $62.66 and a 200 day moving average of $65.27. Innospec Inc. has a 12-month low of $44.06 and a 12-month high of $74.75. The firm has a market cap of $1.50 billion, a price-to-earnings ratio of 18.72 and a beta of 1.28.
Innospec (NASDAQ:IOSP) last released its earnings results on Tuesday, February 14th. The specialty chemicals company reported $1.09 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.89 by $0.20. The firm earned $237.80 million during the quarter, compared to analyst estimates of $231.70 million. Innospec had a return on equity of 15.53% and a net margin of 10.17%. Innospec’s revenue was down 3.3% compared to the same quarter last year. During the same period last year, the business posted $1.24 earnings per share. On average, equities research analysts predict that Innospec Inc. will post $4.08 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This news story was reported by WKRB News and is the sole property of of WKRB News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at http://www.wkrb13.com/markets/2065484/kirr-marbach-co-llc-in-has-12-681-million-position-in-innospec-inc-iosp.html.
Separately, Zacks Investment Research cut Innospec from a “hold” rating to a “sell” rating in a report on Monday, January 2nd.
In other Innospec news, VP Catherine Hessner sold 3,664 shares of Innospec stock in a transaction dated Friday, February 17th. The stock was sold at an average price of $70.91, for a total transaction of $259,814.24. Following the completion of the sale, the vice president now directly owns 30,705 shares of the company’s stock, valued at approximately $2,177,291.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Patrick Williams sold 3,000 shares of Innospec stock in a transaction dated Friday, March 17th. The stock was sold at an average price of $63.01, for a total value of $189,030.00. Following the sale, the chief executive officer now directly owns 200,265 shares of the company’s stock, valued at $12,618,697.65. The disclosure for this sale can be found here. Insiders have sold a total of 11,821 shares of company stock valued at $814,527 over the last ninety days. 2.56% of the stock is owned by company insiders.
Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.
Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP).
This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/2065484/kirr-marbach-co-llc-in-has-12-681-million-position-in-innospec-inc-iosp.html
Receive News & Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related companies with MarketBeat.com's FREE daily email newsletter.